JWJean-Philippe Wolf

Jean-Philippe Wolf

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jean-Philippe Wolf has a total of 113 co-authors. Here are the top co-authors by number of shared publications:

  • Ahmed Ziyyat

    Institut Cochin

    5 shared publications
  • Daniel Vaiman

    Département « From Gametes To Birth : Génomique, Épigénétique et Physiopathologie de la Reproduction », Institut Cochin, INSERM U1016, CNRS UMR8104, Université Paris Cité, France

    3 shared publications
  • Virginie Barraud-Lange

    Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Universitaire Paris Centre (HUPC), Centre Hospitalier Universitaire (CHU) Cochin, Paris, France

    3 shared publications
  • Amira Sallem

    Reproductive Biology Department of the Center of Maternity and Neonatology of Monastir, Fattouma Bourguiba University Hospital, Monastir, Tunisia.

    2 shared publications
  • Anne-Lyse Denizot

    Team "From Gametes To Birth", Institut Cochin, Inserm U1016, CNRS UMR8104, Université de Paris, 22 rue Mechain, 75014, Paris, France

    2 shared publications
  • Anne-Sophie Gille

    Département de Génétique, Développement et Cancer. Team From Gametes to Birth, Institut Cochin, INSERM U1016, Paris, France

    2 shared publications

Latest Publications

  • Open Access

    Beyond Conventional Semen Analysis: Targeted Sperm Gene-Expression Markers Associated with Semen Quality and IVF/ICSI Outcomes

    by Kamshat Nigmetova, Nino Guy Cassuto, Jean-Philippe Wolf, Yeldar Ashirbekov, Yenglik Askar, Betty Meiri-Ferber, Sholpan Karibaeva, Kamalidin Sharipov, Aimira Begimbaeva, Zhuldyz Sailau, et al.

    Background: Conventional semen analysis remains the cornerstone of male infertility diagnostics; however, its predictive value for fertilization potential and assisted reproductive technology (ART) outcomes remains limited. Molecular alterations in spermatozoa may contribute to impaired reproductive outcomes even in men with normozoospermia. Objective: To investigate the associations between targeted sperm expression profiles of AURKA, HDAC4, and CARHSP1 and conventional semen quality, fertilization, embryo development, and pregnancy outcomes in IVF/ICSI programs. Materials and Methods: This combined prospective-retrospective observational study included 173 men undergoing IVF treatment between March 2024 and January 2025 at the International Clinical Center for Reproductive Medicine PERSONA, Almaty, Kazakhstan. Sperm expression levels of AURKA, HDAC4, and CARHSP1 were analyzed by RT-qPCR using the EurobioPlex Sperm Messenger 4 Fertility assay. Based on the manufacturer-defined Sperm Function Index (SFI), samples were categorized as having normal, intermediate, or reduced gene-expression profiles. Among 99 normozoospermic men, two with intermediate expression profiles were excluded from the comparative IVF/ICSI outcome analysis, resulting in a final subgroup of 97 men (70 normal expression and 27 reduced expression). Embryological outcomes were analyzed using generalized estimating equations (GEE) with patient-level clustering to account for multiple oocytes and embryos originating from the same patient. Results: Among the 173 analyzed samples, 56% had normal, 42% reduced, and 2% intermediate gene-expression profiles. Among the individual target transcripts, CARHSP1 was significantly associated with conventional semen quality, with higher expression in normozoospermic men than in men with abnormal semen parameters (p < 0.001). Notably, 27.2% of normozoospermic men exhibited reduced gene-expression profiles despite normal conventional semen parameters. Within the normozoospermic subgroup, reduced expression was associated with lower fertilization (68.2% vs. 81.8%; OR = 0.48, 95% CI 0.36–0.63; p < 0.000001), blastocyst formation (38.7% vs. 53.5%; OR = 0.60, 95% CI 0.42–0.84; p = 0.0034), and good-quality day-5 blastocyst development (9.9% vs. 19.4%; OR = 0.50, 95% CI 0.30–0.85; p = 0.0106). Among patients with an evaluable embryo transfer, positive hCG was observed in 14.3% of the reduced-expression group compared with 51.7% of the normal-expression group (p = 0.0065); given the limited number of events, this finding should be considered exploratory. Conclusions: Targeted sperm gene-expression analysis identified a molecularly distinct subgroup of normozoospermic men with reduced expression profiles associated with poorer fertilization, blastocyst development, good-quality day-5 blastocyst formation, and biochemical pregnancy outcomes. These findings suggest that targeted sperm gene-expression assessment may provide additional information beyond conventional semen analysis. However, these associations should not be interpreted as evidence of causality, and larger prospective multicenter studies incorporating relevant male, female, and cycle-related factors and live-birth outcomes are required before clinical implementation.

  • Fertilin peptide decreases embryo resorption and improves live birth rate in mouse

    by Sophie Favier, Audrey L’HOstis, Rémi Pierre, Isabelle Lagoutte, Eric Vicaut, Daniel Vaiman, Jean Philippe Wolf


  • Open Access

    Plastic used in in vitro fertilization procedures induces massive placental gene expression alterations

    by Franck Kouakou, Anne-Lyse Denizot, Audrey L'HOstis, Julie Colet, Sébastien Jacques, Amira Sallem, Ahmed Ziyyat, Daniel Vaiman, Jean-Philippe Wolf


  • Open Access

    An interpretable and versatile machine learning approach for oocyte phenotyping

    by Gaelle Letort, Adrien Eichmuller, Christelle Da Silva, Elvira Nikalayevich, Flora Crozet, Jeremy Salle, Nicolas Minc, Elsa Labrune, Jean-Philippe Wolf, Marie-Emilie Terret, et al.

    Meiotic maturation is a crucial step of oocyte formation allowing its potential fertilization and embryo development. Elucidating this process is important both for fundamental research and assisted reproductive technology. Few computational tools based on non-invasive measurements are however available to characterize oocyte meiotic maturation. Here, we develop a computational framework to phenotype oocytes based on images acquired in transmitted light. We trained neural networks to segment the contour of oocytes and their zona pellucida using oocytes from diverse species. We defined a comprehensive set of morphological features to describe an oocyte. These steps are implemented in an open-source Fiji plugin. We present a feature based machine learning pipeline to recognize oocyte populations and determine their morphological differences. We first demonstrate its potential to screen oocyte from different strains and automatically identify their morphological characteristics. Its second application is to predict and characterize the maturation potential of oocytes. We identify the texture of the zona pellucida and the cytoplasmic particles size as features to assess mouse oocyte maturation potential and tested whether these features were applicable to human oocyte's developmental potential.


  • Open Access

    Cyclic fertilin-derived peptide stimulates in vitro human embryo development

    by Anne-Lyse Denizot, Audrey L’hOstis, Amira Sallem, Sophie Favier, Rémi Pierre, Marcio Do Cruzeiro, Thomas Guilbert, Philippe Burlet, Jean-Michel Lapierre, Mathieu Robain, et al.


  • Open Access

    A fertilin-derived peptide improves in vitro maturation and ploidy of human oocytes

    by Amira Sallem, Anne-Lyse Denizot, Ahmed Ziyyat, Audrey L’hOstis, Sophie Favier, Philippe Burlet, Jean-Michel Lapierre, Solohaja Faniaha Dimby, Catherine Patrat, Christophe Sifer, et al.


  • Open Access

    Cyclic FEE Peptide Improves Human Sperm Movement Parameters without Modification of Their Energy Metabolism

    by Nathalie Le Foll, Jean-Christophe Pont, Audrey L’hostis, Thomas Guilbert, Frédéric Bouillaud, Jean-Philippe Wolf, Ahmed Ziyyat

    Cyclic fertilin peptide (cFEE: phenylalanine, glutamic acid; glutamic acid) improves gamete interaction in humans. We investigate whether it could be via improvement of sperm movement parameters and their mitochondrial ATP production. Sperm movement parameters were studied using computer-assisted sperm analysis (CASA) in sperm samples from 38 patients with normal sperm in medium supplemented with cyclic fertilin against a control group. Sperm mitochondrial functions were studied using donor’s sperm, incubated or not with cFEE. It was evaluated by the measurement of their ATP production using bioluminescence, their respiration by high resolution oxygraphy, and of mitochondrial membrane potential (MMP) using potentiometric dyes and flow cytometry. cFEE significantly improved sperm movement parameters and percentage of hyperactivated sperm. Impact of inhibitors showed OXPHOS as the predominant energy source for sperm movement. However, cFEE had no significant impact on any of the analyzed mitochondrial bioenergetic parameters, suggesting that it could act via a more efficient use of its energy resources.


  • Hydroxyurea does not affect the spermatogonial pool in prepubertal patients with sickle cell disease

    by Anne-Sophie Gille, Corinne Pondarré, Jean-Hugues Dalle, Françoise Bernaudin, Céline Chalas, Mony Fahd, Camille Jean, Harry Lezeau, Lydia Riou, Véronique Drouineaud, et al.

    In these two short reports, the authors approach the issue of whether hydroxyurea (HU) use in young males has major irreversible effects on sperm production. Joseph et al analyzed and compared sperm parameters in male patients with sickle cell disease (SCD) who were exposed or not exposed to HU before puberty. They report semen abnormalities in all patients but no differences between groups. Independently, Gille et al provide evidence for the lack of in vivo HU-related decreases in the spermatogonial pool in biopsy specimens from young males with SCD but evidence for a negative effect of SCD itself. Together, these reports suggest that the use of HU in young males does not adversely affect fertility.


  • Open Access

    Partial Sperm beta1 Integrin Subunit Deletion Proves Its Involvement in Mouse Gamete Adhesion/Fusion

    by Virginie Barraud-Lange, Côme Ialy-Radio, Céline Chalas, Isabelle Holtzmann, Jean-Philippe Wolf, Sandrine Barbaux, Ahmed Ziyyat

    We have previously shown, using antibodies, that the sperm alpha6beta1 integrin is involved in mouse gamete fusion in vitro. Here we report the conditional knockdown of the sperm Itgb1 gene. It induced a drastic failure of sperm fusogenic ability with sperm accumulation in the perivitelline space of in vitro inseminated oocytes deleted or not for the Itgb1 gene. These data demonstrate that sperm, but not oocyte, beta1 integrin subunit is involved in gamete adhesion/fusion. Curiously, knockdown males were fertile in vivo probably because of the incomplete Cre-mediated deletion of the sperm Itgb1 floxed gene. Indeed, this was shown by Western blot analysis and confirmed by both the viability and litter size of pups obtained by mating partially sperm Itgb1 deleted males with females producing completely deleted Itgb1 oocytes. Because of the total peri-implantation lethality of Itgb1 deletion in mice, we assume that sperm that escaped the Itgb1 excision seemed to be preferentially used to fertilize in vivo. Here, we showed for the first time that the deletion, even partial, of the sperm Itgb1 gene makes the sperm unable to normally fertilize oocytes. However, to elucidate the question of the essentiality of its role during fertilization, further investigations using a mouse expressing a recombinase more effective in male germ cells are necessary.


  • Open Access

    Transgender fathering: children’s psychological and family outcomes

    by Agnès Condat, Grégor Mamou, Chrystelle Lagrange, Nicolas Mendes, Joy Wielart, Fanny Poirier, François Medjkane, Julie Brunelle, Véronique Drouineaud, Ouriel Rosenblum, et al.

    Medical advances in assisted reproductive technology have created new ways for transgender persons to become parents outside the context of adoption. The paucity of empirical data does not support the idea that trans-parenthood negatively impacts children’s development. However, the question has led to lively societal debates making the need for evidence-based studies urgent. We aimed to compare cognitive development, mental health, gender identity, quality of life and family dynamics using standardized instruments and experimental protocols in 32 children who were conceived by donor sperm insemination (DSI) in couples with a cisgender woman and a transgender man, the transition occurring before conception. We constituted two control groups matched for age, gender and family status. We found no significant difference between groups regarding cognitive development, mental health, and gender identity, meaning that neither the trans factor nor the use of DSI had any impact on these characteristics. The results of the descriptive analysis showed positive psycho-emotional development. Additionally, when we asked raters to differentiate the family drawings of the group of children of trans-fathers from those who were naturally conceived, no rater was able to differentiate the groups above chance levels, meaning that what children expressed through family drawing did not indicate cues related to trans-fatherhood. However, when we assessed mothers and fathers with the Five-Minute Speech Sample, we found that the emotions expressed by transgender fathers were higher than those of cisgender fathers who conceived by sex or by DSI. We conclude that the first empirical data regarding child development in the context of trans-parenthood are reassuring. We believe that this research will also improve transgender couple care and that of their children in a society where access to care remains difficult in this population. However, further research is needed with adolescents and young adults.